MedTrace Logo

To Demonstrate the Relative Bioavailability of Diclofenac Sodium 75 mg Enteric-Coated Tablets Under Non-Fasting Conditions

NCT00913887 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2017-03-28

No results posted yet for this study

Summary

To demonstrate the relative bioavailability of Diclofenac Sodium 75 mg enteric-coated tablets under non-fasting conditions.

Conditions

Interventions

DRUG

Diclofenac Sodium 75 mg Tablets Under Fasting Conditions (Geneva Pharmaceutical)

DRUG

Diclofenac Sodium 75 mg Tablets Under Fed Conditions (Geneva Pharmaceutical)

DRUG

Voltaren 75 mg Tablets Under Fed Conditions (Geigy Pharmaceuticals)

Sponsors & Collaborators

Principal Investigators

  • Paul D. Larsen, M.D. · Red River Clinical

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1994-04-30
Primary Completion
1994-05-31
Completion
1994-05-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00913887 on ClinicalTrials.gov